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Objectives: To describe the variability in renal function markers in non-azotaemic and 16 
azotaemic cats and also the rate of change in the markers. 17 
Methods:  Plasma creatinine concentration and its reciprocal, glomerular filtration rate 18 
(GFR) and urine specific gravity (USG) were studied as markers of renal function in client 19 
owned cats. GFR was determined using a corrected slope-intercept iohexol clearance 20 
method. Renal function testing was performed at baseline and a second time point. The 21 
within-population variability (coefficient of variation; CV%) was determined at the 22 
baseline time-point. Within-individual variability (CV%) and rate of change over time 23 
was determined from the repeated measurements. 24 
Results: Twenty-nine cats were included in the study of which five had azotaemic chronic 25 
kidney disease. The within-individual variability (CV%) in creatinine concentration was 26 
lower in azotaemic cats compared to non-azotaemic cats (6.81% vs. 8.82%) whereas, the 27 
within-individual variability in GFR was higher in azotaemic cats (28.94% vs. 19.98%). 28 
The within-population variability was greatest for USG (67.86% in azotaemic cats and 29 
38.00% in non-azotaemic cats). There was a negative rate of change in creatinine 30 
concentration in azotaemic and non-azotaemic cats (-0.0265 and -0.0344 µmol/l/day 31 
respectively) and a positive rate of change of GFR in azotaemic and non-azotaemic cats 32 
(0.0062 and 0.0028 ml/min/day respectively). 33 
Conclusions and relevance: The within-individual variability data suggests creatinine 34 
concentration to be the more useful marker for serial monitoring of renal function in 35 
azotaemic cats. In contrast, in non-azotaemic cats, GFR is a more useful marker for serial 36 
monitoring of renal function. The majority of cats with azotaemic CKD did not have an 37 
appreciable decline in renal function during the study.  38 
 39 
Introduction 40 
Important clinical applications of renal function testing include early detection of 41 
renal dysfunction and monitoring for progressive disease. Plasma or serum creatinine 42 
concentration is the most widely used renal function test in veterinary clinical practice 43 
and is a surrogate marker of glomerular filtration rate (GFR). There exists an exponential 44 
relationship between creatinine and GFR so that in early chronic kidney disease (CKD) 45 
there can be large changes in GFR with relatively small changes in creatinine 46 
concentration.1 Therefore, creatinine is considered insensitive for detecting early CKD. 47 
In addition, factors other than GFR can influence creatinine concentration, most notably 48 
muscle mass. Reference intervals determined by individual laboratories for creatinine are 49 
variable.2 This can lead to misclassification of patients as normal or abnormal depending 50 
on the laboratory to which the sample is submitted.2  51 
GFR is considered the most sensitive and accurate measurement of functioning 52 
renal mass. Limited3 and single4 sampling plasma clearance techniques have been 53 
validated for cats facilitating measurement of GFR and making it practical and accessible 54 
for patients in clinical practice. However, reference intervals remain poorly defined. 55 
It is recognized that better methods for early detection of CKD are required for 56 
cats. Considering the limitations of using reference intervals and specific cut-offs to 57 
define if a patient has normal or abnormal renal function and the insensitivity of single 58 
measurements of creatinine for early kidney disease, repeated measurements in which 59 
each patient serves as its own control may provide more clinically useful information 60 
when evaluating change in renal function. This requires knowledge of the normal 61 
variability in measurement between two time points. It also allows more dynamic rather 62 
than static assessment of renal function. Furthermore, an increase in creatinine 63 
concentration or decrease in GFR greater than the expected variability in cats with stable 64 
CKD, may suggest more progressive CKD and prompt the clinician to change the 65 
management plan or monitor the cat more closely. 66 
The study objectives were twofold; firstly, to describe the variability in serum creatinine 67 
concentration, GFR and USG as markers of renal function in non-azotaemic and 68 
azotaemic patients and secondarily to describe the rate of change in the markers. 69 
 70 
Materials and methods 71 
Study population 72 
Client-owned senior cats (>9 years) with varying renal function were identified through 73 
a senior cat wellness screening programme that was conducted at a London-based first 74 
opinion practice (Beaumont Sainsbury Animals’ Hospital, Royal Veterinary College). 75 
Cats with evidence of concurrent medical disease such as hyperthyroidism were 76 
excluded. Informed consent was obtained from the owners and the study was conducted 77 
with approval from the Royal Veterinary College’s Ethics and Welfare committee.  78 
Measurement of renal function markers 79 
GFR was determined using a previously described slope-intercept iohexol clearance 80 
method.3 Briefly, a bolus dose of iohexol (OmnipaqueTM [647mg/ml; 300mg of 81 
iodine/ml]) was administered intravenously (1ml/kg). Blood samples were collected at 82 
120, 180 and 240 min post-injection. Iohexol concentrations were determined at an 83 
external commercial laboratory using a HPLC methodi. Clearance was determined as 84 
dose/AUC where AUC is area under the plasma concentration versus time curve 85 
determined using a one-compartment model. A previously validated cat specific 86 
correction formula for slope-intercept clearance was applied to correct for the one 87 
compartment assumption.3 In addition, creatinine concentrations were determined from a 88 
sample collected at the same time as GFR measurement. USG was determined from a 89 
urine sample collected by cystocentesis prior to the administration of iohexol. For 90 
statistical analysis, one was subtracted from USG. 91 
Renal function testing, as described above, was performed at baseline and repeated 92 
approximately 6 months after the initial measurement. Measurements were therefore 93 
performed at two time-points in each cat. 94 
Cats were classified as having azotaemic CKD if they had a persistently increased plasma 95 
creatinine concentration above the laboratory reference interval (> 2.0 mg/dl [177 96 
µmol/l]) in association with decreased urine concentrating ability (USG < 1.035). Non-97 
azotaemic cats did not receive any drugs or diet that might influence GFR during the 98 
study period. Azotaemic cats did not receive any drugs that may influence GFR, however, 99 
renal diet was offered to all azotaemic cats, the intake of which was variable.  100 
 101 
Data analysis 102 
Descriptive statistics only were performed due to the small numbers of cats included in 103 
the study and the high variability between cats that would limit the statistical power if 104 
performing inferential statistics. 105 
Percent variation (CV;%) was calculated as (standard deviation [SD]/mean) x 100.  Rate 106 
of change over time was calculated as (measurement time-point 2 – measurement time-107 
point 1)/ number of days between measurements. GFR unscaled to body weight (i.e. 108 
ml/min) was also included to ensure variations in weight were not influencing variation 109 
in GFR. Units for rate of change of the reciprocal of creatinine were converted to 110 
l/mmol/day. 111 
 112 
Results 113 
There were a total of 29 cats included in the study. Five of these cats had azotaemic CKD. 114 
The median (range) age was 12.1 (7.8 – 19.0) years. Of the 29 cats, 14 were female 115 
neutered and 15 were male neutered. Twenty cats were DSH/DLH and nine cats were 116 
pedigree (two Burmese, two Russian blue, two Persian, British short hair, Bengal and 117 
Ocicat). Repeated measurements of GFR were performed a mean number of 234 days 118 
following initial measurement. The within-population variability (CV%) for creatinine 119 
concentration, reciprocal of creatinine, USG and GFR was greater in both azotaemic and 120 
non-azotaemic cats compared to the within-individual variation (see Table 1) except for 121 
non-standardised GFR in azotaemic cats. Azotaemic cats had lower within-individual 122 
variability for creatinine concentration (6.81 vs 8.82%; see Table 1) and USG (13.19% 123 
vs 26.66%; see Table 1) compared to non-azotaemic cats. The within-individual 124 
variability in GFR was higher in azotaemic versus non-azotaemic cats (28.94% vs 125 
19.98%). The mean within-individual body weight in azotaemic and non-azotaemic cats 126 
was 4.62kg and 4.25kg respectively and the mean within-individual variability 4.65% and 127 
5.44% respectively.  128 
 129 
The rate of change of creatinine concentration was negative in both azotaemic (-0.0265 130 
µmol/l/day; see Table 2) and non-azotaemic cats (-0.0344 µmol/l/day). There was a 131 
positive rate of change of GFR in both azotaemic and non-azotaemic cats (0.0062 132 
ml/min/day and 0.0028 ml/min/day respectively). The mean ± SD rate of change of 133 
BW in azotaemic and non-azotaemic cats was 0.0009 ± 0.0008kg and -0.0005 ± 134 
0.0017kg. 135 
 136 
Discussion 137 
Repeated measurements of renal function were performed in cats with varying renal 138 
function to investigate within-individual variability and changes in kidney function over 139 
time. The within-population variability in renal function markers is larger when 140 
compared to the within-individual variation. Therefore serial monitoring of renal 141 
markers in which each cat serves as its own baseline may prove to be more useful in the 142 
earlier detection of disease than evaluating a single static measurement using a defined 143 
cut-off with a dichotomous diagnosis (does the cat have or not have azotaemia). 144 
The within-individual variability (CV%) in creatinine concentration was lower in 145 
azotaemic cats compared to non-azotaemic cats (6.81% vs 8.82%) whereas, the within-146 
individual variability in GFR was higher in azotaemic cats (28.94% vs 19.98%). These 147 
values were similar to those reported in human patients with normal renal function in 148 
which the within-individual variation in creatinine concentration was 5.8% and GFR 149 
was 18.7%.5 The results of the present study suggest that if performing serial 150 
monitoring in a patient that is azotaemic, creatinine may be the more useful marker as 151 
normal within-individual variability is lower and an increase in concentration is more 152 
likely to be clinically significant. In contrast, there is lower within-individual variability 153 
in GFR in non-azotaemic cats and a decline in GFR is more likely to be clinically 154 
significant. Considering the exponential relationship between creatinine concentration 155 
and GFR it is apparent that in early stages of disease there are large decreases in GFR 156 
with a correspondingly small increases in creatinine concentration but in later stages of 157 
disease, when the change in GFR is smaller, the increase in creatinine concentration is 158 
greater. This would also support the use of creatinine as a monitoring tool for patients 159 
with abnormal renal function and GFR as monitoring tool for patients with normal or 160 
borderline renal function. The reason as to the greater within-individual variability in 161 
GFR in azotaemic patients in unclear. GFR is biologically more variable due to the 162 
influence of renal haemodynamics and fluid volume status whereas the production of 163 
endogenous creatinine is relatively constant. The within-individual variability in GFR 164 
does suggest that in cats with azotaemic CKD, there still remains functional renal 165 
reserve. However, the influence of feeding a renal diet cannot be completely excluded. 166 
All of the azotaemic cats in the present study were in IRIS stage 2 and 3 and none of the 167 
cats were in advanced stage (IRIS stage 4) CKD. It has been shown in cats with 168 
surgically induced models of kidney disease that following partial nephrectomy, the 169 
kidneys undergo renal hypertrophy and that this correlates with an increase in single 170 
nephron GFR.6, 7 It is possible that the cats included in the study also underwent similar 171 
renal hypertrophy. Renal biopsies were not performed to explore this hypothesis further. 172 
It is possible that some of the variability in GFR could reflect poor assay repeatability, 173 
however, it is reported that the methodological imprecision associated with iohexol 174 
analysis is minor compared to biological variation in GFR.8  175 
A further finding of interest in the present study is the positive slope for the rate of 176 
change of GFR in both azotaemic and non-azotaemic cats. This supports the suggestion 177 
that azotaemic cats do indeed have sufficient functional renal reserve to increase their 178 
GFR.  This may be the result of hyperfiltration of remaining nephrons which is a 179 
presumed maladaptive process contributing to progressive CKD, however, further 180 
studies would be required to investigate this. There was a corresponding decrease in 181 
creatinine concentration in azotaemic cats over time. One may assume this is due to 182 
increased renal clearance of creatinine. It is possible that decreased endogenous 183 
production of creatinine due to reduced muscle mass in azotaemic cats may also 184 
contribute to a reduced creatinine concentration over time, however, the positive rate of 185 
change in body weight would not support this. 186 
The within-population variation in USG was high in all cats but particularly in 187 
azotaemic cats (67.86% in azotaemic cats vs 38.00% in non-azotaemic cats). This most 188 
likely reflects the influence of non-renal factors such as water intake or diet on USG and 189 
highlights the limitations of using a single static urine sample in interpretation of renal 190 
function. USG can range from 1.001 to 1.080 in cats with normal renal function and 191 
cats that have undergone surgical ablation of the kidneys have been shown to retain 192 
significant urine concentrating ability. The within-individual variability in USG 193 
(13.19% in azotaemic cats and 26.66% in non-azotaemic cats) was lower than the 194 
within-population suggesting that serial monitoring of USG may prove more useful in 195 
detecting change in renal function compared to a single static measurement. USG is a 196 
simple clinical measurement that can be obtained from a urine sample perhaps collected 197 
by an owner at home and further longitudinal studies evaluating this marker would be 198 
an area for future study. A single USG measurement at baseline has not been found to 199 
predict the development of azotaemic CKD in cats within a 12-month follow up period.9 200 
However, rate of change has not been studied. 201 
The reciprocal of creatinine has been suggested to be a useful marker of progression of 202 
kidney disease. Serial measurement of GFR and the reciprocal of creatinine in canine 203 
remnant kidney models found poor correlation.6 In the present study, the correlation 204 
between rate of change of the reciprocal of creatinine and GFR in cats was not significant 205 
in either azotaemic (r = -0.24, P = 0.695) or non-azotaemic (r = 0.21, P = 0.334) cats.  206 
Longitudinal measurements in human patients with early CKD identified a severe 207 
decrease in eGFR (>4ml/min/year) in 24%, moderate decrease in eGFR (1-208 
4ml/min/year) in 28%, mild decrease in eGFR (0-1ml/min/year) in 10% and no decrease 209 
in eGFR in 38% of patients.10 In the present study, there were only a small number of 210 
cats included with azotaemic CKD (n=5) and of these cats only 1/5 (20%) had a 211 
decrease in GFR over time. It is possible that the remaining azotaemic cats belonged to 212 
a subset of diseased population in which there is no progressive decline in renal 213 
function or it may be that the repeated measurements were performed over an 214 
insufficient time period. A recent study that assessed renal function over a 6 month 215 
follow-up period also reported that in the dogs with IRIS stage 2 CKD, there was no 216 
change in GFR.11 217 
The wide use of electronic clinical record systems in the majority of veterinary practices 218 
may facilitate monitoring of serial measurements of creatinine and/or GFR in clinical 219 
patients. Rate of decline of renal function could be incorporated into IRIS guidelines to 220 
help classify patients with early stage CKD or progressive disease. Furthermore, an 221 
increase in creatinine concentration variability (CV%) above that considered to be 222 
normal within-individual variation (e.g. 6.81% in azotaemic cats and 8.82% in non-223 
azotaemic cats) could be bought to the attention of the clinician prompting closer 224 
monitoring or a change in management for the patient.  225 
It remains unclear how many cats with early stage CKD have intrinsic kidney damage 226 
that is likely to progress. Furthermore, there are no studies examining renal pathology in 227 
these early stages of naturally occurring disease. The fibrotic and inflammatory changes 228 
typically reported in cats with chronic kidney disease likely just reflect a chronic and 229 
irreversible disease process associated with late stage disease. By monitoring serial 230 
measurements and observing an increase in creatinine concentration or decrease in GFR 231 
above the expected norm suggesting declining renal function and potential on-going 232 
intrinsic renal damage, would be a strong argument for performing renal biopsy. This 233 
could provide valuable information regarding pathophysiology of disease. 234 
There are a number of limitations to the present study not least the small number of cats 235 
particularly those with azotaemic CKD that were included.  Only two repeated 236 
measurements were performed with a mean 234 day interval. This may not be a 237 
sufficient number of samples to detect a clinically significant measure of the rate of 238 
change in an individual patient and further longitudinal studies with additional 239 
measurements over a longer time course could provide further information. A further 240 
limitation is that the population of cats studied mainly included older cats. However, 241 
given that this is the population in which CKD is most commonly recognised and often 242 
present the greatest diagnostic challenge, the findings were considered to be 243 
representative. In addition, the findings of the study cannot be extrapolated to cats with 244 
concurrent disease such as hyperthyroidism that may itself affect renal function, as cats 245 
with concurrent disease were excluded.  246 
 247 
Conclusions 248 
The within-individual variability in creatinine concentration is lower in azotaemic cats 249 
compared to non-azotaemic cats which, coupled with the insensitivity of creatinine as a 250 
marker of early renal dysfunction, suggests it is a more useful marker for serial 251 
monitoring of renal function in azotaemic cats. In contrast, the within-individual 252 
variability in GFR is lower in non-azotaemic cats and its sensitivity as a marker of early 253 
renal dysfunction suggests it is a more useful marker for serial monitoring of renal 254 
function in non-azotaemic cats. The majority of cats with azotaemic CKD included in 255 
the study did not have a decline in renal function defined by decreasing GFR which may 256 
suggest that there was sufficient adaptation of remaining functioning nephrons to 257 
increase GFR over the time period studied. 258 
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Table 1: Within-population and within-individual mean, SD and CV for creatinine and reciprocal of 295 
creatinine concentration, USG, and GFR in azotaemic and non-azotaemic cats. 296 
  Mean 
within-
population 
(baseline) 
SD within-
population 
(baseline) 
CV within-
population 
(baseline) 
Mean within-
individual 
Mean SD 
within-
individual 
Mean CV within-
individual 
Creatinine 
(µmol/l) 
All cats 153.96 55.33 35.94% 150.79 12.29 8.47% 
Azotaemic cats 247.80 58.10 23.45% 244.22 15.81 6.81% 
Non-azotaemic 
cats 
134.40 28.75 21.39% 131.32 11.55 8.82% 
        
All cats 0.007 0.002 28.57% 0.007 0.001 8.47% 
Azotaemic cats 0.004 0.001 25.00% 0.004 <0.001 6.81% 
Reciprocal 
creatinine 
(l/µmol) 
Non-azotaemic 
cats 
0.008 0.002 25.00% 0.008 0.001 8.82% 
USG All cats 0.046 0.020 43.48% 0.042 0.011 23.85% 
Azotaemic cats 0.028 0.019 67.86% 0.025 0.004 13.19% 
Non-azotaemic 
cats 
0.050 0.019 38.00% 0.047 0.012 26.66% 
GFR 
(ml/min/kg) 
All cats 1.63 0.63 38.65% 7.91 1.64 21.53% 
Azotaemic cats 0.84 0.37 44.05% 4.39 1.35 28.94% 
Non-azotaemic 
cats 
1.80 0.54 30.00% 8.64 1.70 19.98% 
GFR (ml/min) All cats 6.80 2.73 40.15% 7.13 1.28 19.01% 
Azotaemic cats 3.51 0.79 22.51% 4.22 1.20 27.03% 
Non-azotaemic 
cats 
7.49 2.48 33.11% 7.74 1.31 17.33% 
 297 
 298 
Table 2: Rate of change per day of creatinine and reciprocal of creatinine concentration, USG and GFR in 299 
azotaemic and non-azotaemic cats. 300 
 Rate of change 
Mean SD 
Creatinine 
(µmol/l/day) 
All cats -0.0331 0.1135 
Azotaemic cats -0.0265 0.1065 
Non-azotaemic cats -0.0344 0.1171 
Reciprocal 
creatinine 
(l/mmol/day) 
All cats 0.0014 0.0062 
Azotaemic cats 0.004 0.0023 
Non-azotaemic cats 0.0016 0.0068 
USG (USG/day) All cats <-0.0001 0.0001 
Azotaemic cats <-0.0001 <0.0001 
Non-azotaemic cats <-0.0001 0.0001 
GFR (ml/min/day) 
All cats 0.0034 0.0105 
Azotaemic cats 0.0062 0.0060 
Non-azotaemic cats 0.0028 0.0113 
 301 
 302 
 303 
